Skip to main content
. 2024 May 14;73(8):1285–1299. doi: 10.2337/db23-0926

Figure 4.

Figure 4

Longitudinal effects in MRI organ metrics over 7 months in individuals with type 2 diabetes achieving at least 5% weight loss (A) or 0.9% reduction in HbA1c (B) or on therapy that included SGLT2is and/or GLP-1RAs compared with all other treatments (C).